Opportunity overview
The provision including supply and delivery of nasal Naloxone. Nasal Naloxone supplied must be licensed for use in the UK, compliant with Medicines and Healthcare products Regulatory Agency (MHRA) standards and of a formulation licensed for use on adults and adolescents aged 14 and over. Timely delivery is required to HMPPS settings across England and Wales, including Public Sector (HMPPS) and Privately Managed Prisons, Youth Custody sites, Approved Premises (AP), Independent Approved Premises (IAPs), and Probation Offices and contact centers.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Orion Medical Supplies
- Published award value
- £3m
- Awarded
- 4 Nov 2025
- Award ID
- 1
- Status
- pending
- Identifier
- GB-COH 8181275
- Location
- Bicester, UKJ14, OX26 4AF, United Kingdom
Orion Medical Supplies
- Contract value
- £3m
- Awarded
- Not supplied
- Contract signed
- 10 Dec 2025
- Including VAT
- £3.6m
- Award ID
- 2
- Status
- active
- Identifier
- GB-COH 8181275
- Location
- Bicester, UKJ14, OX26 4AF, United Kingdom
Classification
- CPV33600000 — Pharmaceutical products
Lots
- Lot 1£3m
Documents and notices
- Contract details notice on Find a TenderOpen source ↗
- Contract award notice on Find a TenderOpen source ↗
- Tender notice on Find a TenderOpen source ↗
- Pipeline notice on Find a TenderOpen source ↗